Showing posts with label Parkinsons. Show all posts
Showing posts with label Parkinsons. Show all posts

Saturday, September 7, 2013

My husband was diagnosed with Parkinson’s disease — what symptoms can we expect?

Posted June 25, 2013, 2:00 am

My husband was just diagnosed with Parkinson’s disease. Can you discuss it in your column? I don’t know anything about it.

Parkinson’s disease (PD) is a disease of the central nervous system. It causes problems with body motions and movement. PD worsens over time.

Brain cells “talk” to each other by making and releasing chemicals called neurotransmitters. When one cell releases a neurotransmitter, another picks up the signal. One type of neurotransmitter is dopamine.

Dopamine is made in an area deep in the brain called the basal ganglia. That is also where movements are coordinated. The dopamine made by cells in the basal ganglia is necessary for the basal ganglia to function properly.

PD develops when dopamine-producing nerve cells (neurons) in the brain die and not enough dopamine is produced. This affects movement. (I’ve put an illustration of this process below.)

In people with Parkinson’s disease, dopamine-producing nerve cells die. As a result, not enough dopamine is produced, making it difficult to control muscle movement.

(Image courtesy of Krames Staywell.) 

PD usually begins as a slight tremor or stiffness that is most obvious at rest. When the hands of a PD sufferer are resting in his lap, they may tremble. But when he reaches for a cup of coffee, for instance, his hands may stop trembling.

As the illness worsens, tremors become more widespread. PD also causes rigidity and a slowing of body movements. A person’s face slowly becomes expressionless. Initiating a movement, like sitting up from a chair, may take many seconds to start. A person walks slowly, with short, quick steps.

If your husband’s PD gets much worse, he will likely have difficulty walking and performing daily activities such as dressing or using utensils. But in some people PD progresses very slowly.

There is no cure for PD, but symptoms can be treated with medications. Medication may not be necessary at first. Treatment usually begins when symptoms interfere with work or home life, or when it becomes difficult to walk or maintain balance.

Medications used to treat PD either boost levels of dopamine in the brain or mimic the effects of dopamine. The most commonly used medication is levodopa. It is usually prescribed in combination with another drug called carbidopa. Other medications can also be used, either alone or in combination with levodopa.

Nearly all patients improve after they start taking levodopa. But long-term use often causes side effects and complications.

Depression is fairly common in people with PD. Antidepressant medications can help. Regular exercise and a balanced diet also may help to improve a patient’s sense of well-being and body control. The type of exercise called tai chi has been shown to help.

Surgery is considered only when medications are no longer effective. Surgical options include deep brain stimulation in which electrical stimulation is delivered to targeted areas of the brain to control symptoms. Another option involves destroying precisely targeted areas of the brain that are responsible for the most troubling symptoms.

We can do a great deal more to help people with PD today than when I was in medical school. Based on the progress of research, I expect more effective treatments in the future.

window.fbAsyncInit = function() { FB.init({appId: "199616670120169", status: true, cookie: true, xfbml: true});}; (function() { var e = document.createElement("script"); e.async = true; e.src = document.location.protocol + "//connect.facebook.net/en_US/all.js"; document.getElementById("fb-root").appendChild(e);}());Share

View the original article here

Monday, August 26, 2013

Muhammad Ali's Daughter Champions Fight Against Parkinson's Disease

News Picture: Muhammad Ali's Daughter Champions Fight Against Parkinson's DiseaseBy Barbara Bronson Gray
HealthDay Reporter

FRIDAY, May 3 (HealthDay News) -- At 71, boxing legend Muhammad Ali -- the only three-time World Heavyweight Champion -- continues to fight his most challenging opponent ever: Parkinson's disease. And according to his daughter, he's still facing life straight on.

"This is the man who when he was fighting would say 'I'm going to knock the other guy out in five,'" said Maryum (May May) Ali. "That personality translates to how he deals with Parkinson's. No one's really been that confident as an athlete, and that's how he is with the disease."

May May is Ali's first child. Married four times, the former champion has six other daughters and two sons.

Thinking back, May May believes Ali was showing signs of Parkinson's in his second-to-last fight, a few years before his 1984 diagnosis. "You lose your [sense of] smell, get constipation issues," she said. "Most people have those non-motor symptoms first. But no one knew that back then."

Initially, in 1981, Ali was told he had a form of the condition that would not progress, May May said. But it did. As time went by, Ali learned how to manage the symptoms of his disease. He took his medications a couple of hours before working out, and he saw a neurologist who specialized in movement disorders, she explained.

Parkinson's disease belongs to a group of conditions called motor system disorders, which result from the loss of dopamine-producing brain cells, according to the U.S. National Institute of Neurological Disorders and Stroke. The four primary symptoms of Parkinson's are trembling in the hands, arms, legs, jaw, and face; stiffness of the limbs and trunk; slowness of movement; and impaired balance and coordination. As the disease progresses, patients may have difficulty walking, talking or completing other simple tasks. In the United States, about 500,000 people have the disease.

"Don't wait until you can't walk down the hallway to get the right advice. You may be able to slow the progression of the disease," May May advised. "Make it your business to know everything you can about what it is that's affecting your life." She also encourages people with Parkinson's to work with a neurologist who specializes in movement disorders.

Committed to raising people's understanding of the disease, May May, 44, has supported the Parkinson Alliance as a spokesperson since 2002. This includes helping publicize its annual Unity Walk, which was held Saturday in New York's Central Park. She also works as a program manager in Los Angeles' gang reduction and youth development program. Divorced, with no children, she said she's committed to helping others and is also studying organizational management at Antioch University.

While some promising new approaches to treating Parkinson's loom on the horizon, researchers say the condition is still poorly understood.

"We have no solid theory of what causes Parkinson's disease," said James Beck, director of research for the Parkinson's Disease Foundation. "We still know so little about the disease. A lot of basic science needs to be funded."

Beck said the drugs available now are designed to help reduce disease symptoms but don't attack their cause. Late-stage clinical trials are looking at what role so-called "A2A receptor antagonists" might play in reducing movement problems. Scientists are also testing possible gene therapy and stem cell applications, and looking at mutations in cell proteins associated with Parkinson's to understand what part they might play. They're also looking at what role, if any, the immune system might have in fighting development of the disease, he explained.

"There's a lot of hope for people with Parkinson's disease -- and progress is being made -- but it needs to be measured hope," Beck said.

Ali, now in the later stages of Parkinson's, has 24-hour care. His personality hasn't changed and "there's no doom and gloom with him," said May May. "He'll look at you, nod his head, and sometimes he can talk a bit, depending on the time of day and when he last took his medications."

Ali flies to his homes in Arizona, Kentucky and Michigan, and loves going to baseball games, May May said. "He's still enjoying life."

"As for spending time with my Dad, I enjoy his company still," she added.

MedicalNews
Copyright © 2013 HealthDay. All rights reserved. SOURCES: Maryum (May May) Ali, Los Angeles, Calif.; James C. Beck, Ph.D., director of research, Parkinson's Disease Foundation, New York City, and adjunct assistant professor, department of physiology and neuroscience, New York University



View the original article here

Friday, June 28, 2013

Early Thinking Problems May Signal Future Dementia in Parkinson's Patients

Title: Early Thinking Problems May Signal Future Dementia in Parkinson's Patients
Category: Health News
Created: 3/25/2013 4:36:00 PM
Last Editorial Review: 3/26/2013 12:00:00 AM

View the original article here

Thursday, June 6, 2013

Pesticide Exposure May Raise Parkinson's Risk, Study Suggests

Farming, country living could play a role, researchers sayFarming methods and plant species play role in

By Alan Mozes

HealthDay Reporter

TUESDAY, May 28 (HealthDay News) -- Prolonged exposure to pesticides, bug and weed killers, and solvents appears to raise the risk for developing Parkinson's disease, a new study says.

Italian investigators who reviewed more than 100 prior studies found exposure to such agents boosted Parkinson's disease risk by anywhere from 33 percent to 80 percent, they reported in the May 28 issue of the journal Neurology.

"Due to this association, there was also a link between farming or country living and developing Parkinson's in some of the studies," study leader Dr. Emanuele Cereda, of the IRCCS University Hospital San Matteo Foundation in Pavia, said in a journal news release.

Some studies specifically explored how home or work environment affected disease risk. Where individuals got their water also was the subject of some investigations.

Exposure either to the weed killer paraquat or the fungicides maneb and mancozeb appeared to double the risk for Parkinson's, a progressive movement disorder, the researchers found.

"We didn't study whether the type of exposure, such as whether the compound was inhaled or absorbed through the skin, and the method of application, such as spraying or mixing, affected Parkinson's risk," Cereda said. "However, our study suggests that the risk increases in a dose response manner as the length of exposure to these chemicals increases."

Although the research found a link between certain chemicals and Parkinson's, it didn't prove they actually cause the disorder.


View the original article here

Wednesday, May 29, 2013

Eating Peppers Tied to Lower Parkinson's Risk, Study Finds

Vegetables that contain nicotine may offer some protection, research suggestsLearn to read food labels closely, he advises.

By Robert Preidt

HealthDay Reporter

THURSDAY, May 9 (HealthDay News) -- Eating vegetables that naturally contain nicotine, such as peppers and tomatoes, may reduce your risk of developing Parkinson's disease, according to a new study.

Previous research has found that smoking and other types of tobacco use are associated with a lower risk of developing Parkinson's disease, and it is believed that nicotine provides the protective effect. Tobacco belongs to a plant family called Solanaceae and some plants in this family are edible sources of nicotine.

This new study included nearly 500 people who were newly diagnosed with Parkinson's and another 650 unrelated people who did not have the neurological disorder, which is typically marked by tremors and other movement problems. The study participants provided information about their tobacco use and diets.

In general, vegetable consumption had no effect on Parkinson's risk. The more vegetables from the Solanaceae plant family that people ate, however, the lower their risk of Parkinson's disease. This association was strongest for peppers, according to the study, which was published May 9 in the journal Annals of Neurology.

The apparent protection offered by Solanaceae vegetables occurred mainly in people with little or no prior use of tobacco, which contains much more nicotine than the foods included in the study.

"Our study is the first to investigate dietary nicotine and risk of developing Parkinson's disease," Dr. Susan Searles Nielsen, of the University of Washington in Seattle, said in a journal news release. "Similar to the many studies that indicate tobacco use might reduce risk of Parkinson's, our findings also suggest a protective effect from nicotine, or perhaps a similar but less toxic chemical in peppers and tobacco."

Nielsen and her colleagues recommended further studies to confirm and extend their findings, which could lead to ways to prevent Parkinson's disease.

Although the study found an association between consumption of certain nicotine-containing foods and lower risk of Parkinson's, it could not prove a cause-and-effect relationship.

Still, one Parkinson's expert called the study "intriguing."

"It provides further evidence of how diet can influence our susceptibility to neurological disease -- specifically Parkinson's disease," said Dr. Kelly Changizi, co-director of the Center for Neuromodulation at the Mount Sinai Parkinson and Movement Disorders Center in New York City. "Patients often ask what role nutrition plays in their disease, so it's very interesting that nicotine in vegetables such as peppers may be neuroprotective."

Another expert said more research into the role of nicotine in Parkinson's disease is already underway.

"The observation that cigarette smokers have a reduced risk for Parkinson's disease has long been known, and has raised the idea that nicotine may reduce the risk for [the illness]," said Dr. Andrew Feigin, who is investigating the illness at the Feinstein Institute for Medical Research in Manhasset, N.Y.

"A nicotine skin patch is currently being tested in patients with early Parkinson's disease," he said.

The illness occurs due to a loss of brain cells that produce a chemical messenger called dopamine. The symptoms of the disease include loss of balance, slower movement and tremors and stiffness in the face and limbs. There is currently no cure for the disorder. Nearly 1 million Americans -- and 10 million people worldwide -- have Parkinson's, according to the Parkinson's Disease Foundation.


View the original article here

Sunday, May 19, 2013

Tai chi improves balance and motor control in Parkinson’s disease

Peter Wayne
Posted May 03, 2013, 8:30 am Senior woman doing Tai Chi Yoga exercise

It isn’t every day that an effective new treatment for some Parkinson’s disease symptoms comes along. Especially one that is safe, causes no adverse side effects, and may also benefit the rest of the body and the mind. That’s why I read with excitement and interest a report in the New England Journal of Medicine showing that tai chi may improve balance and prevent falls among people with Parkinson’s disease.

This degenerative condition can cause many vexing problems. These range from tremors and stiffness to a slowing or freezing of movement, sleep problems, anxiety, and more. Parkinson’s disease may also disrupt balance, which can lead to frightening and damaging falls.

A team from the Oregon Research Institute recruited 195 men and women with mild to moderate Parkinson’s disease. They were randomly assigned to twice-weekly sessions of either tai chi, strength-building exercises, or stretching. After six months, those who did tai chi were stronger and had much better balance than those in the other two groups. In fact, their balance was about two times better than those in the resistance-training group and four times better than those in the stretching group. The tai chi group also had significantly fewer falls, and slower rates of decline in overall motor control. In addition, tai chi was safe, with little risk of Parkinson’s disease patients coming to harm.

Other smaller studies have reported that tai chi can improve quality of life for both people with Parkinson’s disease and their support partners.

These studies are significant because they suggest that tai chi can be used as an add-on to current physical therapies and medications to ease some of the key problems faced by people with Parkinson’s disease.

Parkinson’s disease affects more than one million Americans. This brain disorder interferes with muscle control, leading to trembling; stiffness and inflexibility of the arms, legs, neck, and trunk; loss of facial expression; trouble swallowing; and a variety of other symptoms, include changes in memory and thinking skills. These changes can greatly reduce the ability to carry out everyday activities and reduce quality of life. Medications can help, but they sometimes have unwanted side effects.

Since the appearance of the New England Journal of Medicine study, tai chi classes specifically for Parkinson’s disease patients have sprung up across the country, and the benefits of tai chi for Parkinson’s disease have been endorsed by the National Parkinson’s Foundation. (You can see a video of a tai chi class at Brigham and Women’s Hospital for people with Parkinson’s disease at the bottom of this post.)

Several colleagues and I have developed a tai chi program for people with Parkinson’s disease. It brings together Harvard Medical School doctors and other clinicians with tai chi experts. The 12-week program uses the traditional tai chi principles that I describe in my newly released book, The Harvard Medical School Guide to Tai Chi: 12 Weeks to a Healthy Body, Strong Heart & Sharp Mind. This program is jointly sponsored by the Parkinson’s Disease and Movement Disorders Center at Beth Israel Deaconess Medical Center and the Osher Center for Integrative Medicine at Brigham and Women’s Hospital and Harvard Medical School. So far, about 50 people have completed the program.

We have also begun a small, preliminary study across multiple Harvard Medical School hospitals focused on understanding the interactions between cognitive function, mobility, and motor function in early stage Parkinson’s disease. The idea is to examine how the mind-body connection of tai chi slows the loss of mobility and cognitive function in individuals recently diagnosed with Parkinson’s disease. The results of this pilot study will be used to guide randomized trials to further test the impact of tai chi.

I foresee a growing number of hospitals in the country developing similar tai chi programs for individuals with Parkinson’s disease. In addition to easing balance problems, and possibly other symptoms, tai chi can help ease stress and anxiety and strengthen all parts of the body, with few if any harmful side effects. I look forward to the day when evidence-based tai chi programs become widely available and used by individuals with Parkinson’s disease world-wide.

Peter Wayne, PhD, is an Assistant Professor of Medicine at Harvard Medical School and the Director of Research for the Osher Center for Integrative Medicine, jointly based at Harvard Medical School and Brigham and Women’s Hospital. He is also the author of The Harvard Medical School Guide to Tai Chi: 12 Weeks to a Healthy Body, Strong Heart & Sharp Mind.

Share

View the original article here

Saturday, April 6, 2013

Deep Brain Stimulation May Help in Early Stages of Parkinson's

Title: Deep Brain Stimulation May Help in Early Stages of Parkinson's
Category: Health News
Created: 2/13/2013 6:36:00 PM
Last Editorial Review: 2/14/2013 12:00:00 AM

View the original article here

Monday, March 4, 2013

Some Parkinson's Patients Discover an Artistic Side

Cases suggest prescribed medicine may help

THURSDAY, Jan. 31 (HealthDay News) -- Some people with Parkinson's disease discover untapped artistic abilities after their diagnosis -- a phenomenon that seems to be related to their dopamine-enhancing medication.

Over the years, reports have popped up in the medical literature on Parkinson's patients who suddenly discover they are painters, sculptors or writers at heart.

Dan Joseph is one of them. After being diagnosed with the movement disorder a dozen years ago, the former doctor eventually took up painting. But it wasn't because he planned on becoming an artist.

"A friend of mine said, 'You're not doing anything. Why don't you paint?'" said Joseph, a 79-year-old Santa Barbara, Calif., resident.

He decided to follow that advice and soon discovered that when he painted, his hand tremors improved. He also discovered that he actually had talent; about six years after first picking up a paintbrush, Joseph has had three solo art exhibitions.

No one knows how common it is for Parkinson's patients to find their inner painter or creative writer, according to Dr. Rivka Inzelberg, of Tel Aviv University and Sheba Medical Center, in Israel.

But when she pulled together past case reports on 14 such patients, Inzelberg found that the phenomenon does appear to be related to treatment with levodopa and so-called dopamine agonists -- Parkinson's drugs that enhance the action of the brain chemical dopamine.

One patient, for example, suddenly became interested in creative writing after starting levodopa and a dopamine agonist. That interest waned, however, when the drug doses were cut, Inzelberg reported in the Jan. 14 online edition of the journal Behavioral Neuroscience.

Parkinson's disease arises when dopamine-producing cells in the brain die off over time. That leads to symptoms such as tremors, rigid muscles, slowed movement and balance problems. Levodopa and dopamine agonists -- drugs like Requip (ropinirole) and Mirapex (pramipexole) -- help make up for that dopamine loss.

But dopamine is not only involved in movement; it's also connected to the brain's "reward system." And it's well known that some Parkinson's patients on dopamine-enhancing drugs develop so-called impulse-control disorders -- such as compulsive gambling and hypersexuality (commonly known as "sex addiction").

Inzelberg said it's possible that for certain Parkinson's patients, the medications lower inhibitions that once held back any creative impulses.

"It is also possible that dopamine is involved in creativity in general," Inzelberg said. That theory, she noted, is based on the observation that artists who suffer psychosis -- which involves excessive dopamine activity -- can become remarkably productive. Think Vincent Van Gogh.

That's all speculation, though. Experts know little about why some people on Parkinson's drugs suddenly find creative inspiration. But it does seem to be related to the medications themselves, agreed Dr. Anhar Hassan, an assistant professor of neurology at the Mayo Clinic in Rochester, Minn., who was not involved in the report.


View the original article here

Thursday, January 24, 2013

Compulsions in Parkinson’s Tied to Treatment

red dice

Jan. 8, 2013 -- Parkinson’s disease itself doesn’t seem to raise a person’s risk for compulsive addictions to things like gambling, shopping, or sex, a new study shows.

Compulsive behaviors affect about 14% of Parkinson’s patients treated with drugs such as dopamine agonists to ease symptoms like tremors, stiffness, and slowness.

In severe cases, the new addictions that people develop on the drugs can be devastating -- leading to ruined finances and relationships -- and they’ve generated a raft of lawsuits against drug manufacturers.

In November, a French man won a high-profile case against the company that sells Requip, which he said turned him into a sex and gambling addict. In 2008, a Minneapolis man won a case involving gambling addiction against the maker of Mirapex.

As a result, dopamine agonists now carry warnings about compulsive behaviors on their labels.

“A missing piece to the story was whether just Parkinson’s disease itself has any effect or plays any role on the risk of having these problems” without the drugs, says researcher Daniel Weintraub, MD, a psychiatrist at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia.

In the largest such study to date, Weintraub and his team set out to answer that question by screening a group of 168 newly diagnosed and untreated people with Parkinson’s for impulsive behaviors. The researchers compared them to a similar group of 143 healthy people who didn’t have the disease.

“What we found was that the reporting of symptoms of impulse control disorders was not any different in the two groups,” Weintraub says.

For example, 1.2% of people with Parkinson’s reported problems related to gambling compared to 0.7% of the healthy group. Compulsive buying behaviors were reported by 3% of the Parkinson’s group compared to 2.1% of the healthy group. About 7% of the Parkinson’s group reported compulsive eating compared to about 11% of the other group. And compulsive sexual behaviors were reported by 4.2% of the Parkinson’s group compared to 3.5% of the healthy group.

Overall, about 20% of both groups showed signs of problems with some kind of impulse control.

The findings, which are in the journal Neurology, are the first published data from the Parkinson’s Progression Markers Initiative, a landmark $50 million effort to follow 400 newly diagnosed patients with Parkinson’s to learn more about how the disease develops. The project is sponsored by the Michael J. Fox Foundation for Parkinson’s Research.

The research echoes the findings of a smaller Italian study, which was published in 2011.

“To have some confirmation of those findings is important,” says Mark Stacy, MD, a neurologist and professor of medicine at Duke University School of Medicine.

Stacy was one of the first doctors to report problems with impulse control in Parkinson’s patients taking dopamine agonists, but he was not involved in this research. He says the new study suggests that compulsions are probably the result of some complex interplay between the drugs and the disease.

Researchers plan to follow these patients for several years to see if people who show poor impulse control before starting the medications may be more likely than those who don’t to develop impulse control disorders on the drugs.

Doctors have no way to predict which patients will have problems on the drugs.

“Hopefully we can determine if there are specific risk factors for these behaviors going forward,” says Martin Niethammer, MD, PhD, a neurologist at North Shore-LIJ’s Movement Disorders Center in Great Neck, N.Y.

“We now know it’s not part of the disease, so anyone who starts these dopamine agonist medications should be told about these problems,” says Niethammer, who was not involved in the research.


View the original article here